RNASE7 Antikörper (N-Term)
-
- Target Alle RNASE7 Antikörper anzeigen
- RNASE7 (Ribonuclease, RNase A Family, 7 (RNASE7))
-
Bindungsspezifität
- N-Term
- Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser RNASE7 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- Spezifität
- Reacts with human RNASE7
- Kreuzreaktivität (Details)
- Cross reacts with human RNASE8 protein
- Aufreinigung
- Purified (protein A)
- Immunogen
- Synthetic peptide derived from Nter domain of human RNASE7
- Top Product
- Discover our top product RNASE7 Primärantikörper
-
-
- Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
IHC1:200 - 1:1000 WB1:500 - 1:5000 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Must be reconstituted in distilled water to reach 1 mg/mL
- Konzentration
- 1 mg/mL
- Buffer
- Tris 0,1M, glycine 0,1M, sucrose 2 %
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
- Haltbarkeit
- 24 months
-
- Target
- RNASE7 (Ribonuclease, RNase A Family, 7 (RNASE7))
- Andere Bezeichnung
- Ribonuclease 7 (RNase 7) (RNASE7 Produkte)
- Synonyme
- ribonuclease A family member 7 antikoerper, RNASE7 antikoerper
- Hintergrund
- Exhibits a potent RNase activity. Has broad-spectrum antimicrobial activity against many pathogenic microorganisms and remarkably potent activity (lethal dose of 90 % < 30 nM) against a vancomycin resistant Enterococcus faecium
- Gen-ID
- 84659
- UniProt
- Q9H1E1
-